BX Swiss TOP 30 CHF
1.185,32
PKT
-2,74
PKT
-0,23
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
Datum | Rating | Analyst | |
---|---|---|---|
12.09.23 | Roche Underweight | JP Morgan Chase & Co. | |
11.09.23 | Nestlé Overweight | JP Morgan Chase & Co. | |
11.09.23 | Givaudan Sell | UBS AG | |
08.09.23 | Richemont Market-Perform | Bernstein Research | |
08.09.23 | Novartis Buy | Deutsche Bank AG | |
07.09.23 | Nestlé Add | Baader Bank | |
07.09.23 | Nestlé Underperform | RBC Capital Markets | |
07.09.23 | Zurich Insurance Overweight | Barclays Capital | |
07.09.23 | Swiss Re Equal Weight | Barclays Capital | |
06.09.23 | Givaudan Sell | UBS AG | |
06.09.23 | Nestlé Market-Perform | Bernstein Research | |
06.09.23 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
05.09.23 | Givaudan Underperform | Bernstein Research | |
05.09.23 | Novartis Buy | Jefferies & Company Inc. | |
05.09.23 | Novartis Buy | Deutsche Bank AG | |
05.09.23 | Swiss Re Equal Weight | Barclays Capital | |
05.09.23 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
04.09.23 | UBS Overweight | JP Morgan Chase & Co. | |
04.09.23 | ABB (Asea Brown Boveri) Market-Perform | Bernstein Research | |
01.09.23 | UBS Buy | Deutsche Bank AG | |
01.09.23 | Richemont Outperform | RBC Capital Markets | |
01.09.23 | Nestlé Overweight | JP Morgan Chase & Co. | |
01.09.23 | Richemont Buy | UBS AG | |
01.09.23 | Roche Underweight | JP Morgan Chase & Co. | |
01.09.23 | Swiss Re Overweight | JP Morgan Chase & Co. | |
01.09.23 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
31.08.23 | Givaudan Sell | UBS AG | |
31.08.23 | Roche Sell | Deutsche Bank AG | |
31.08.23 | Novartis Buy | Deutsche Bank AG | |
31.08.23 | UBS Buy | Deutsche Bank AG | |
31.08.23 | UBS Hold | Jefferies & Company Inc. | |
31.08.23 | UBS Sector Perform | RBC Capital Markets | |
31.08.23 | Novartis Neutral | JP Morgan Chase & Co. | |
31.08.23 | Givaudan Neutral | JP Morgan Chase & Co. | |
29.08.23 | Roche Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
24.08.23 | Givaudan Sell | UBS AG | |
24.08.23 | Roche Neutral | UBS AG | |
24.08.23 | Roche Underweight | JP Morgan Chase & Co. | |
23.08.23 | Nestlé Market-Perform | Bernstein Research | |
23.08.23 | Roche Equal Weight | Barclays Capital |